Dr. Rifkin-Zenenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Prospect Ave
Hackensack, NJ 07601Phone+1 551-996-5437Fax+1 201-487-7340
Summary
- Dr. Stacey Rifkin-Zenenberg is a pediatric hematologist/oncologist based in Hackensack, NJ. She completed her residency in pediatrics at Rutgers Health/Newark Beth Israel Medical Center and her fellowship in pediatric hematology/oncology at Zucker School of Medicine. Dr. Rifkin-Zenenberg currently serves as the Section Chief, Pediatric Pain and Palliative Care at Joseph Sanzari Children’s Hospital, where she also practices as a pediatric hematologist/oncologist. She has prior experience at Newark Beth Israel Medical Center. She is recognized for contributions to significant publications such as "Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C", and "Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease", among others. She has also participated in several clinical trials related to sickle cell disease and B-cell NHL. She is a Fellow of American Academy of Pediatrics (FAAP).
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology, 1998 - 2001
- Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 1995 - 1998
- Philadelphia College of Osteopathic MedicineClass of 1995
Certifications & Licensure
- NY State License 1997 - 2026
- NJ State License 1997 - 2025
- PA State License 1997 - 2005
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Hospice and Palliative Medicine
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Academy of Medical Acupuncture Full Member
- Children's Mercy Hospital/University of Missouri-Kansas City School of Medicine Certificate Program in Pediatric BioEthics of the Children's Mercy BioEthics Center
Awards, Honors, & Recognition
- Fellow, FAAHPM American Academy of Hospice and Palliative Medicine, 2024
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
- Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
- Join now to see all
Publications & Presentations
PubMed
- 127 citationsBiologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.Julie Kanter, Mark C Walters, Lakshmanan Krishnamurti, Markus Y Mapara, Janet L Kwiatkowski
The New England Journal of Medicine. 2022-02-17 - 129 citationsRate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.Hilary B. Whitworth, Sarah E. Sartain, Riten Kumar, Katherine Armstrong, Lance Ballester
Blood. 2021-07-15
Press Mentions
- Bluebird Bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 5th, 2024
- Medical Breakthrough Cures 5-Year-Old New Jersey Boy of Sickle Cell AnemiaOctober 26th, 2023
Professional Memberships
- Member
- Fellow
- Member
- Member
- American Society of Pediatric Hematology OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: